Thursday, 01 May 2014 13:30 Senate Dems Take Aim At

New Post Public Reply Private Reply Replies (0) Message Board
SaltyMutt
Thursday, 01 May 2014 13:30
Senate Dems Take Aim At First Amendment
Written by Jack Kenny


Senate Dems Take Aim At First Amendment


Democrats in the U.S. Senate are planning a vote sometime this year on a proposed constitutional amendment to overturn two U.S. Supreme Court decisions on campaign spending, The Hill reported Wednesday. Legislation sponsored by Sen. Tom Udall (D-N.M.) calls for amending the Constitution to negate high court rulings in Citizens United v. Federal Elections Commission and McCutcheon v. FEC.

In its 2010 Citizens United decision, the court ruled in favor of a non-profit organization that had sought to advertise its unfavorable documentary film about Hillary Clinton shortly before the Iowa Caucuses and the New Hampshire primaries of 2008, when then-Sen. Clinton (D-N.Y.) was a candidate for her party's nomination for president. The court struck down provisions of the Bipartisan Campaign Reform Act of 2002 that prohibited independent expenditure ads that mention a candidate within 30 days of a primary or 90 days of a general election in which that candidate is running. By a 5-4 vote, the justices declared that the freedom of speech guarantee of the First Amendment prohibits restrictions on expenditures by individuals or corporations, including non-profit corporations.

In last month's McCutcheon decision, five justices ruled against limits on how much a donor may spend in total in contributions to a number of candidates in any year's federal elections.

"The Supreme Court is trying to take this country back to the days of the robber barons, allowing dark money to flood our elections," said Senate Rules Committee Chairman Charles Schumer (D-N.Y.) in announcing the amendment plan. "That needs to stop, and it needs to stop now." Schumer predicted that the vote would take place by year's end, and he called on Republicans to join with Democrats in supporting the amendment so "the wealthy can't drown out middle-class voices in our Democracy."

Udall's bill calls for an amendment that would authorize both Congress and state legislatures to enact limits on fundraising and spending for and by candidates for federal office and on independent expenditures by outside groups. It would deny the judiciary power to overturn such legislation. If passed by two thirds of each house of Congress, the measure would have to be ratified by three fourths of the states to become an amendment to the U.S. Constitution. It is unlikely to survive the first of those tests however, since congressional Republicans generally oppose campaign finance restrictions.

The First Amendment states unequivocally that "Congress shall make no law ... abridging the freedom of speech, or of the press." In the Citizens United and the McCutcheon rulings, the Supreme Court rejected the argument that the free speech limitations enacted by Congress serve a compelling government interest by limiting the corrupting influence of money in politics.

Concerning another legislative proposal threatening the freedom of speech, a Boston Herald editorial recently took Sen. Edward Markey (D-Mass.) to task over Markey's proposed "Hate Crime Reporting Act of 2014," a measure the Herald described as "a frankly chilling proposition." The bill would require an obscure federal agency, the National Telecommunications and Information Administration, to report to Congress on "the use of telecommunications ... to advocate and encourage violent acts and the commission of crimes of hate." Noting that authority already exists to prosecute threats, the Herald warned that under Markey's bill, "new government hall monitors" would determine "what qualifies as impermissible speech" and then recommend to Congress steps that would be, in the language of the bill, "appropriate and necessary to address such use of telecommunications." Such actions must be, the bill says, "consistent with the First Amendment." The Herald, among others, is more than a little skeptical about that assurance.

"And for the life of us," the editorial proclaimed, "we can't fathom any further government limit on Internet postings or talk radio callers that could be structured to protect an American's right to free expression." To civil liberties lawyer Harvey Silvergate the bill is "worse than merely silly. It is dangerous.... It is not up to Sen. Markey, nor to the federal government, to define for a free people what speech is, and is not, acceptable."

Now the Massachusetts’ junior U.S. senator, Markey, 67, served for more than 26 years in the U.S. House before winning a special election last June to fill the unexpired term of Sen. John Kerry, who had resigned from the Senate to become the U.S. Secretary of State. Markey is an Army veteran and holds a Bachelor of Arts degree from Boston College and a doctorate from the Boston College Law School. Somehow, with all that education and experience, the senator still does not comprehend that "Congress shall make no law" abridging the freedom of speech means that Congress shall make no law that abridges the freedom of speech. Perhaps he has been so busy preparing and promoting unconstitutional legislation that he hasn't had time to read the Bill of Rights lately — or even have an aide brief him on it.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 240

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 956

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 188

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 471

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 251

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 366

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 98

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 289

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Future Leaders: Vantage Partners with AIESEC

Updated Category News Views 285

Vantage as a Platinum Partner of AIESEC FHN Vantage is proud to highlight its inspirational collaboration with AIESEC FHN, a partnership dedicated to empowering youth leadership development. This initiative significantly impacted the career trajectories of numerous young individuals seeking growth within a competitive landscape. The Mission of AIESEC AIESEC stands as a...

Continue Reading
Nicox Reports Strong Q4 2024 Financial Performance and Outlook

Updated Category News Views 140

Nicox Excels in Fourth Quarter Financial Performance Nicox SA, an international ophthalmology company known for its innovative solutions, has unveiled its financial performance for the fourth quarter of 2024. The results reflect the company's resilience and strategic direction as it continues to navigate the complexities of the ophthalmic landscape. Key Financial...

Continue Reading
International Paper's Strategic Move to Acquire DS Smith in Europe

Updated Category News Views 193

International Paper's New Acquisition Strategy International Paper, a prominent player in the packaging industry based in the United States, has recently achieved a significant milestone by receiving the European Union's approval for its acquisition of DS Smith, a UK competitor. This strategic move, valued at approximately $7.2 billion, comes as part of International...

Continue Reading
Market Movements: Futures, Debates and GameStop's Trends

Updated Category News Views 251

Markets Today: Futures, Debate Fallout, and Sector Shifts Stock futures are drifting lower as traders weigh two things at once: upcoming US inflation data and a combative debate between presidential candidates Donald Trump and Kamala Harris. The exchange was lively—lots of heat, fewer specifics—leaving investors still hunting for clear economic plans. Meanwhile,...

Continue Reading
Trogenix Launches Innovative Cancer Treatment Platform to Save Lives

Updated Category News Views 123

Trogenix: A Revolutionary Approach to Cancer Treatment In the rapidly evolving domain of cancer therapies, Trogenix Ltd has emerged with a groundbreaking platform designed to transform cancer treatment, especially for aggressive forms like glioblastoma. Originating from the innovative research of the University of Edinburgh, Trogenix is on a mission to elevate the...

Continue Reading